Aller au contenu
Global sound
Life Sciences DNA Podcast

Life Sciences DNA Podcast

de Levine Media Group

Dernier épisode
Why Scaling AI Starts with Leadership, not Technology

À propos de ce podcast

The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.

Épisodes

Les 20 épisodes les plus récents sur 53

  • Why Scaling AI Starts with Leadership, not Technology · 44 min · Épisode 56Moving AI beyond a pilot requires more than choosing a model or building a tool. It requires leadership support, employee trust, and a clear connection to business results. On…
  • Putting Business Value at the Center of AI in Biopharma · 45 min · Épisode 55Artificial intelligence may be moving quickly, but life sciences companies cannot afford to treat it as a race for the latest shiny tool. In this episode of Life Sciences DNA…
  • Turning Data and AI Into Better Business Outcomes · 53 min · Épisode 54Artificial intelligence is reshaping how biopharmaceutical companies discover, develop, commercialize, and support medicines. But realizing its potential requires far more than…
  • Measuring AI by Business Results in Life Sciences · 54 min · Épisode 53Artificial intelligence is creating new opportunities to improve clinical development, but successful adoption requires more than choosing the latest model or launching isolated…
  • Lessons from Insmed’s Journey to an AI First Biotech · 46 min · Épisode 52Chris Colucci, vice president of information technology at Insmed, sits down with Nagaraja Srivatsan to discuss the company’s shift from AI experimentation to enterprise-scale…
  • Making AI Transformations that Stick · 53 min · Épisode 50Vikram Nair, chief information officer of Amneal Pharmaceuticals, joins Srivatsan Nagaraja to break down what it really takes to turn AI from boardroom buzz into real business…
  • Finding ROI from AI in the Mundane · 46 min · Épisode 48Dennis Salotti, executive director and head of clinical outsourcing and innovation at Jazz Pharmaceuticals, joins Srivatsan Nagaraja to talk about what AI really looks like in…
  • A Pragmatic Path to AI-Enabled Commercial Operations · 37 min · Épisode 47Tris Pharma Chief Commercial Officer Manesh Naidu sits down with Nagaraja Srivatsan to discuss how the small but growing specialty pharma company is pursuing a deliberately…
  • Reimagining Scientific Work in the Age of AI Agents · 47 min · Épisode 46Shweta Maniar, global strategy and market leader for life sciences at Google Cloud, sits down with Nagaraja Srivatsan to unpack what it takes to turn AI pilots into durable…
  • Orchestrating Scientists, Data, and AI to Discover New Drugs · 46 min · Épisode 45Scotch McClure had a bold plan for Maxwell Biosciences to map and mine the roughly 3 percent of peptides circulating in human plasma. The company has harnessed AI to move from a…
  • Scaling Practical AI Across Commercial Teams · 49 min · Épisode 44Drew McCormick, head of data and analytics at Eversana, sits down with Nagaraja Srivatsan to trace the company’s AI journey from classic predictive modeling in its data and…
  • Building an AI-Ready Biopharma Organization · 55 min · Épisode 42Scott Cenci, chief information and data officer for Acadia Pharmaceuticals, sits down with Nagaraja Srivatsan to discuss how generative and agentic AI are reshaping biopharma…
  • Automating Biopharma Workflows with AI and Robotics · 38 min · Épisode 41Karthik Raman, co-founder and CEO of Persist AI, sits down with the Nagaraja Srivatsan to discuss how robotics, AI, and cloud tech are supercharging drug formulation to address a…
  • De-Risking Discovery and Improving the Success Rates of Drug Development with AI · 42 min · Épisode 40Gabi Tarcic, vice president of product for Evogene, sits down with Srivatsan Nagaraja about applying AI to small molecule drug discovery, the cultural and operational changes…
  • Agents of Change: Creating Regulatory Documents with AI · 42 min · Épisode 39Anita Modi, CEO and founder of Peer AI, joins Srivatsan Nagaraja to discuss the transformative impact of agentic AI on document creation for pharmaceutical companies. She…
  • Redefining Biomarkers for Immune-Mediated Disease with AI · 1 min · Épisode 38Ronel Veksler, co-founder and CEO of PromiseBio, sits down with Amar Drawid to discuss the company’s AI-enabled proteomics platform, and how post-translational modifications of…
  • Driving Insights from Real World Oncology Data with AI · 4 min · Épisode 37Aaron Cohen, Head of Research Oncology, Clinical Data for Flatiron Health, sits down with Amar Drawid to discuss Flatiron’s use of large language models to extract and analyze…
  • Improving Drug Development with Real-World Data · 1 h 0 min · Épisode 36Manfred Stapff, founder and principal of Candid Advisory, sits down with Amar Drawid to discuss the potential of real-world data to accelerate drug development and improve…
  • Navigating the AI Landscape in Clinical Development · 48 min · Épisode 35Stephen Pyke, chief clinical data and digital officer at Parexel, sits down with Srivatsan Nagaraja to discuss the adoption of AI technologies in clinical development. He…
  • Transforming Cancer Diagnostics and Care with AI · 59 min · Épisode 34Mohan Uttarwar, CEO 1Cell.Ai, sits down with Amar Drawid to discuss how his company is transforming cancer diagnostics and care by combining cutting-edge molecular science with…

Dans le même genre

Tous les podcasts Sciences →

En direct, dernière heure : 8 343 titres sur 3 486 stations dans 133 pays

Découvrez le monde par la radio

Plus de façons de découvrir (9)

Vous avez entendu quelque chose de bien ? Enregistrez-le, ou ouvrez-le directement dans Spotify.

Radio 538 luisteren - Live!Populaire en ce moment